Person:

Tsiaras, William

Loading...
Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Tsiaras

First Name

William

Name

Tsiaras, William

Search Results

Now showing 1 - 2 of 2
  • Publication

    Intractable pyoderma gangrenosum in a Crohn's disease patient on vedolizumab

    (Elsevier, 2017) Yeh, Jennifer; Tsiaras, William
  • Publication

    Risk of Developing Pyoderma Gangrenosum after Procedures in Patients with a Known History of Pyoderma Gangrenosum – A Retrospective Analysis

    (Elsevier BV, 2017) Xia, Fandi; Liu, Kristina; Lockwood, Stephen J.; Butler, Daniel Charles; Tsiaras, William; Joyce, Cara; Mostaghimi, Arash

    Background

    The risk of postoperative pyoderma gangrenosum (PG) in patients with a known history of PG is unknown.

    Objective

    To quantify risk and identify patient/procedure-related risk factors for postsurgical PG recurrence/exacerbation in patients with known history of PG.

    Methods

    We retrospectively evaluated the likelihood of postsurgical PG recurrence/exacerbation for all patients with a confirmed diagnosis of PG at Brigham & Women’s Hospital and Massachusetts General Hospital from 2000-2015.

    Results

    5.5% (n=33) of procedures led to recurrence of PG in 15.1% (n=25) of patients. Compared to skin biopsy, small open surgeries had an adjusted odds ratio (aOR) of 8.65 (1.55, 48.33) for PG recurrence/exacerbation; large open surgeries had an aOR of 5.97 (1.70, 21.00); and Mohs surgery/skin excision had an aOR of 6.47 (1.77, 23.61). PG chronically present at the time of procedure had an aOR of 4.58 (1.72, 12.22). Immunosuppression, time elapsed since original PG diagnosis, and procedure location did not significantly influence risk.

    Limitations

    Our study is limited by its retrospective nature and relatively small sample size.

    Conclusion

    There is a small but clinically meaningful risk of postsurgical PG recurrence/exacerbation in patients with known history of PG; higher risks occur with more invasive procedures and chronically present PG.